AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30967128 — intervention group
Group type: COMPARATOR
Intervention: Retro walking
Number of subjects: 68
Study 30967128 — intervention group
Group type: COMPARATOR
Intervention: Forward walking
Number of subjects: 68
Study 30967128 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study 28079814 — intervention group
Group type: EXPERIMENTAL
Intervention: Lens-decentration group
Number of subjects: 60
Study 28079814 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 28079814 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC curve analysis
Number of subjects: 60
Study 26319652 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy program (overall stretching, specific stretches, Kegel exercises, jogging, and relaxation exercises) for three months
Number of subjects: 160
Study 26319652 — intervention group
Group type: COMPARATOR
Intervention: No intervention program
Number of subjects: 160
Study 23368826 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal
Number of subjects: 12
Study 23368826 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 12
Study 20579847 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructo-oligosaccharides (FOS) 10 g/d
Number of subjects: 10
Study 20579847 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-FOS period
Number of subjects: 10
Study 20579847 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 mL of fructose syrup)
Number of subjects: 10
Study 19279365 — intervention group
Group type: EXPERIMENTAL
Intervention: CDC model early stimulation therapy (home-based)
Number of subjects: 800
Study 19279365 — intervention group
Group type: COMPARATOR
Intervention: Routine postnatal check-up as per hospital practice
Number of subjects: 800
Study 18022209 — intervention group
Group type: EXPERIMENTAL
Intervention: Achromatic COCE with contours modulated along the luminance axis of the DKL color space
Number of subjects: 0
Study 18022209 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromatic COCE with contours modulated along the L‐M or S‐(L+M) axis
Number of subjects: 0
Study 15033892 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2 microg ml(‐1) in bupivacaine 0.1%
Number of subjects: 99
Study 15033892 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 5 microg ml(‐1) in bupivacaine 0.1%
Number of subjects: 99
Study 15033892 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 10 microg ml(‐1) in bupivacaine 0.1%
Number of subjects: 99
Study 11463988 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim (r-metHuG-CSF)
Number of subjects: 0
Study 9587125 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain surgery
Number of subjects: 34
Study 9587125 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery
Number of subjects: 34
Study 9587125 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam radiation therapy
Number of subjects: 34
Study 9587125 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy for metastatic disease
Number of subjects: 34
Study 9587125 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with doxorubicin-containing regimens
Number of subjects: 34
Study 7522747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermia treatment
Number of subjects: 0
Study 7522747 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study 2970122 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence techniques
Number of subjects: 200
Study 2970122 — intervention group
Group type: COMPARATOR
Intervention: Clinician diagnosis
Number of subjects: 200
Study 29144799 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel total thyroidectomy
Number of subjects: 269
Study 29144799 — intervention group
Group type: COMPARATOR
Intervention: Classic total thyroidectomy
Number of subjects: 269
Study 28077826 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized birth control program (4 weeks)
Number of subjects: 42
Study 28077826 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 42
Study 24921253 — intervention group
Group type: EXPERIMENTAL
Intervention: WASH indicators used in classification and regression trees (C&RT) analysis
Number of subjects: 0
Study 24921253 — intervention group
Group type: EXPERIMENTAL
Intervention: WASH indicators used in conditional inference trees (CIT) analysis
Number of subjects: 0
Study 22550196 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil capsules (four 1-g capsules/d)
Number of subjects: 201
Study 22550196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 20819892 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted H5N1 vaccine (7.5 μg/dose)
Number of subjects: 472
Study 20819892 — intervention group
Group type: COMPARATOR
Intervention: MF59-adjuvanted trivalent seasonal influenza control vaccine (15 μg/dose for each antigen)
Number of subjects: 472
Study 18165395 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 100 mg/d
Number of subjects: 707
Study 18165395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 707
Study 15853463 — intervention group
Group type: EXPERIMENTAL
Intervention: WAD patients
Number of subjects: 92
Study 15853463 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI lesions to the alar ligaments
Number of subjects: 92
Study 15853463 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI lesions to the transverse ligament and posterior atlanto-occipital membrane
Number of subjects: 92
Study 15853463 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing number of abnormal (grade 2-3) structures
Number of subjects: 92
Study 15853463 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 persons)
Number of subjects: 92
Study 12913696 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical electromotive mitomycin C (40 mg with 20 mA electric current for 30 minutes)
Number of subjects: 108
Study 12913696 — intervention group
Group type: COMPARATOR
Intervention: Passive transport mitomycin C (40 mg with a dwell time of 60 minutes)
Number of subjects: 108
Study 12913696 — intervention group
Group type: COMPARATOR
Intervention: Bacillus Calmette‐Guerin (81 mg with a dwell time of 120 minutes)
Number of subjects: 108
Study 10351971 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing from the posterior wall (PW) or coronary sinus ostium (CSO)
Number of subjects: 22
Study 10351971 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing from the lateral wall (LW)
Number of subjects: 22
Study 10351971 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing from the posterior wall (PW)
Number of subjects: 22
Study 7725890 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 1.0 mg.kg‐1 i.v. after general anaesthesia induction, before surgical incision, and four hours later the same dose was given i.m.
Number of subjects: 90
Study 7725890 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 1.35 mg.kg‐1 i.v. and i.m.
Number of subjects: 90
Study 7725890 — intervention group
Group type: COMPARATOR
Intervention: Saline control (comparable volume i.v. and i.m.)
Number of subjects: 90
Study 2029413 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam radiation therapy
Number of subjects: 0
Study 2029413 — intervention group
Group type: COMPARATOR
Intervention: Radical prostatectomy
Number of subjects: 0
Study 7028759 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-drug chemotherapy with local radiotherapy (5-FU and local radiotherapy to a dose of 4600 rad, then Methyl-CCNU)
Number of subjects: 59
Study 7028759 — intervention group
Group type: COMPARATOR
Intervention: Multi-drug chemotherapy without radiotherapy (5-FU and Methyl-CCNU)
Number of subjects: 59
Study 7028759 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-drug chemotherapy with local radiotherapy
Number of subjects: 59
Study 7028759 — intervention group
Group type: COMPARATOR
Intervention: Multi-drug chemotherapy without radiotherapy
Number of subjects: 59
Study 30998046 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term psychoanalytic psychotherapy (LTPP)
Number of subjects: 0
Study 30998046 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 29127417 — intervention group
Group type: EXPERIMENTAL
Intervention: Xueshuan Xinmai tablets (XXMT)
Number of subjects: 44
Study 29127417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 27507715 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopic Colectomy (SILC)
Number of subjects: 200
Study 27507715 — intervention group
Group type: COMPARATOR
Intervention: Multiport Laparoscopic Colectomy (MPLC)
Number of subjects: 200
Study 24992753 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at hour-prescriptive points (9 to 11 AM)
Number of subjects: 72
Study 24992753 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture at any time beyond 9 to 11 AM (control group)
Number of subjects: 72
Study 22691451 — intervention group
Group type: EXPERIMENTAL
Intervention: SCORES intervention (multi-component PA and FMS intervention)
Number of subjects: 0
Study 22691451 — intervention group
Group type: EXPERIMENTAL
Intervention: SCORES intervention
Number of subjects: 0
Study 20826623 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsaturated fat diet
Number of subjects: 162
Study 20826623 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein diet
Number of subjects: 162
Study 20826623 — intervention group
Group type: COMPARATOR
Intervention: Self-selected diets
Number of subjects: 162
Study 18394772 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine slow-release tablets (60 mg/d)
Number of subjects: 14
Study 18394772 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system (GITS) tablets (90 mg/d)
Number of subjects: 14
Study 15744147 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-viral IL-2 gene therapy
Number of subjects: 10
Study 15744147 — intervention group
Group type: COMPARATOR
Intervention: Control plasmid in cationic lipid formulation
Number of subjects: 10
Study 15744147 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate chemotherapy
Number of subjects: 10
Study 15744147 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin in combination with IL-2 gene therapy
Number of subjects: 10
Study 12866363 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEP lecithin
Number of subjects: 100
Study 12866363 — intervention group
Group type: COMPARATOR
Intervention: DHEP gel
Number of subjects: 100
Study 10394695 — intervention group
Group type: EXPERIMENTAL
Intervention: Group health education workshop for two days in the first and second years
Number of subjects: 243
Study 10394695 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 243
Study 9082374 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg/d)
Number of subjects: 147
Study 9082374 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 mg/d)
Number of subjects: 147
Study 8453465 — intervention group
Group type: EXPERIMENTAL
Intervention: Acallosal subjects
Number of subjects: 24
Study 8453465 — intervention group
Group type: COMPARATOR
Intervention: IQ-matched controls
Number of subjects: 24
Study 8453465 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 24
Study 8453465 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual pointing response mode
Number of subjects: 24
Study 8453465 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral response mode
Number of subjects: 24
Study 8453465 — intervention group
Group type: EXPERIMENTAL
Intervention: Left and right field stimulus presentation
Number of subjects: 24
Study 3021502 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 0
Study 3021502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29730489 — intervention group
Group type: EXPERIMENTAL
Intervention: diet-only
Number of subjects: 323
Study 29730489 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise-only
Number of subjects: 323
Study 29730489 — intervention group
Group type: EXPERIMENTAL
Intervention: combined diet and exercise
Number of subjects: 323
Study 27681572 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus four 2.5-h weekly sessions of theory-based lifestyle structured group education, maintenance contact every 2 weeks, and 'booster' sessions every 3 months.
Number of subjects: 396
Study 24243918 — intervention group
Group type: EXPERIMENTAL
Intervention: Excitatory rTMS (10 Hz)
Number of subjects: 5
Study 24243918 — intervention group
Group type: COMPARATOR
Intervention: Inhibitory rTMS (1 Hz)
Number of subjects: 5
Study 24243918 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 5
Study 24486422 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg of methylphenidate (MPH)
Number of subjects: 12
Study 24486422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 22147473 — intervention group
Group type: COMPARATOR
Intervention: SFC (steam-flaked corn) diet with 0% WDG (wet distillers grain plus solubles)
Number of subjects: 600
Study 22147473 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC with increasing WDG concentrations (15, 30, 45, 60% DM basis)
Number of subjects: 600
Study 22147473 — intervention group
Group type: COMPARATOR
Intervention: DRC (dry-rolled corn) diet without WDG
Number of subjects: 600
Study 22147473 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC diet
Number of subjects: 600
Study 22147473 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing WDG concentrations
Number of subjects: 600
Study 19214892 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 155
Study 19214892 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraductal endoscopic ultrasonography (EDUS)
Number of subjects: 155
Study 19214892 — intervention group
Group type: COMPARATOR
Intervention: Comparison of EUS vs EDUS
Number of subjects: 155
Study 17445284 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol (all treatment groups)
Number of subjects: 155
Study 17445284 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL-C (all treatment groups)
Number of subjects: 155
Study 17445284 — intervention group
Group type: EXPERIMENTAL
Intervention: TAG (all treatment groups)
Number of subjects: 155
Study 15883577 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication-assisted manipulation (MAM)
Number of subjects: 68
Study 15883577 — intervention group
Group type: COMPARATOR
Intervention: Spinal manipulation therapy (SMT)
Number of subjects: 68
Study 12517610 — intervention group
Group type: EXPERIMENTAL
Intervention: Endonasal endoscopic surgery
Number of subjects: 44
Study 12517610 — intervention group
Group type: COMPARATOR
Intervention: Sublabial transsphenoidal microsurgery
Number of subjects: 44
Study 9791356 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing
Number of subjects: 100
Study 9791356 — intervention group
Group type: COMPARATOR
Intervention: Hydrocellular dressing
Number of subjects: 100
Study 8918026 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% plain lidocaine
Number of subjects: 12
Study 8918026 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% plain bupivacaine (Marcaine)
Number of subjects: 12
Study 8918026 — intervention group
Group type: EXPERIMENTAL
Intervention: 50/50 mixture of 1% lidocaine and 0.25% bupivacaine
Number of subjects: 12
Study 8918026 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 12
Study 1885426 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir 200 mg five times daily for five days
Number of subjects: 54
Study 1885426 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir 400 mg twice daily for five days
Number of subjects: 54
Study 1885426 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir 200 mg twice a day for five days
Number of subjects: 54
Study 6357901 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon-arc photocoagulation treatment in one eye
Number of subjects: 99
Study 6357901 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 99
Study 30774040 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative message
Number of subjects: 378
Study 30774040 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 378
Study 30774040 — intervention group
Group type: COMPARATOR
Intervention: Loss-framed messages
Number of subjects: 378
Study 28912163 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 49
Study 28912163 — intervention group
Group type: COMPARATOR
Intervention: Face mask (FM)
Number of subjects: 49
Study 26936623 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site bundled rapid HIV/HCV testing intervention
Number of subjects: 0
Study 26936623 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 25525349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST) plus carer training
Number of subjects: 68
Study 25525349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST) only
Number of subjects: 68
Study 25525349 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 68
Study 21681516 — intervention group
Group type: EXPERIMENTAL
Intervention: Dienogest (2 mg once daily, orally)
Number of subjects: 168
Study 19349517 — intervention group
Group type: COMPARATOR
Intervention: Nikkomycin Z 250 mg
Number of subjects: 12
Study 19349517 — intervention group
Group type: COMPARATOR
Intervention: Nikkomycin Z 1,000 mg
Number of subjects: 12
Study 19349517 — intervention group
Group type: COMPARATOR
Intervention: Nikkomycin Z 1,500 mg to 2,000 mg
Number of subjects: 12
Study 19349517 — intervention group
Group type: EXPERIMENTAL
Intervention: Nikkomycin Z (all doses)
Number of subjects: 12
Study 17484872 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2b/ribavirin for 48 weeks (group B)
Number of subjects: 81
Study 17484872 — intervention group
Group type: COMPARATOR
Intervention: no treatment (group A)
Number of subjects: 81
Study 17484872 — intervention group
Group type: EXPERIMENTAL
Intervention: severe recurrence treatment (group C)
Number of subjects: 81
Study 17484872 — intervention group
Group type: EXPERIMENTAL
Intervention: treatment (overall)
Number of subjects: 81
Study 17484872 — intervention group
Group type: EXPERIMENTAL
Intervention: treated patients (overall)
Number of subjects: 81
Study 15139869 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix Model (manualized 16-week treatment)
Number of subjects: 978
Study 15139869 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 978
Study 15139869 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix Model
Number of subjects: 978
Study 11782895 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized diosmin (Daflon 500 mg)
Number of subjects: 12
Study 11782895 — intervention group
Group type: COMPARATOR
Intervention: Nonmicronized diosmin
Number of subjects: 12
Study 9824860 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversed Tip and Snip technique
Number of subjects: 60
Study 9824860 — intervention group
Group type: COMPARATOR
Intervention: Divide and Conquer technique
Number of subjects: 60
Study 7854294 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking (NNS)
Number of subjects: 12
Study 7854294 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NNS)
Number of subjects: 12
Study 2065410 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine patch (0.75 mg or 0.375 mg)
Number of subjects: 50
Study 2065410 — intervention group
Group type: COMPARATOR
Intervention: Control group (no patch)
Number of subjects: 50
Study 7073303 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose trimethoprim-sulphamethoxazole
Number of subjects: 42
Study 7073303 — intervention group
Group type: COMPARATOR
Intervention: 7-day course of trimethoprim-sulphamethoxazole
Number of subjects: 42
Study 31036580 — intervention group
Group type: EXPERIMENTAL
Intervention: Ace‐ER 6 g/d
Number of subjects: 89
Study 31036580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 28527855 — intervention group
Group type: EXPERIMENTAL
Intervention: XR-NTX treatment prior to release
Number of subjects: 15
Study 28527855 — intervention group
Group type: COMPARATOR
Intervention: Post-release XR-NTX treatment
Number of subjects: 15
Study 26044070 — intervention group
Group type: EXPERIMENTAL
Intervention: bapineuzumab 0.15 mg/kg
Number of subjects: 26
Study 26044070 — intervention group
Group type: EXPERIMENTAL
Intervention: bapineuzumab 0.5 mg/kg
Number of subjects: 26
Study 26044070 — intervention group
Group type: EXPERIMENTAL
Intervention: bapineuzumab 1.0 mg/kg
Number of subjects: 26
Study 26044070 — intervention group
Group type: EXPERIMENTAL
Intervention: bapineuzumab 2.0 mg/kg
Number of subjects: 26
Study 26044070 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26
Study 25104109 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day
Number of subjects: 1199
Study 25104109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1199
Study 25104109 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 1199
Study 22196270 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Number of subjects: 0
Study 18985345 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (0.3 mg/kg i.v.)
Number of subjects: 24
Study 18985345 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 18985345 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 24
Study 17901415 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty (BT)
Number of subjects: 32
Study 17901415 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 15682684 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2) treatment (2.8 atmospheres absolute, 100 minutes, three treatments within the first 24 hours)
Number of subjects: 8
Study 12195070 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable-angle Roman chair exercise group
Number of subjects: 36
Study 12195070 — intervention group
Group type: COMPARATOR
Intervention: Control group (no resistance exercise)
Number of subjects: 36